- 06.27.13 03:47 PM EDT
Scientists at Stanford University published findings on Wednesday from trials conducted for a DNA-based vaccine treating Type 1 diabetes. This form is the most severe and can also be called early-onset or juvenile since people are born with this disease.
The "reverse" vaccine has the opposite effect of most. That means that instead of boosting immune responses, it actually stops them. In this case, the vaccine would shut down the part of the immune system that destroys insulin-producing cells in the pancreas.
If continuing trials go well, this could be the first DNA-based vaccine approved for human use.